Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408
更正:Bajbouj 等人,《VEGFR 激酶抑制剂、乐伐替尼和瑞戈非尼联合治疗的协同抗血管生成作用:乳腺癌的治疗潜力》,《国际分子科学杂志》,2022 年,23 卷,4408 页。
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms27020743
Bajbouj, Khuloud; Qaisar, Rizwan; Alshura, Mohammed A; Ibrahim, Zeinab; Alebaji, Mohamad B; Al Ani, Amenah W; Janajrah, Hanadi M; Bilalaga, Mariah M; Omara, Abdelrahman I; Abou Assaleh, Rebal S; Saber-Ayad, Maha M; Elmoselhi, Adel B
肿瘤
肿瘤免疫
信号转导
EGF
乳腺癌
EGFR
VEGF
血管生成